Abstract
BackgroundImmune cell-based therapies with monocytes-derived macrophages and/or dendritic cells (DC), both phagocytic antigen-presenting cells (APCs), have arisen to be a powerful branch of immunotherapy against cancer. The promises of phagocytic...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
